Financial Year |
March 31 2023 |
Monetary Funds |
1,361,607,826.27 |
Held-for-trading Financial Assets |
325,683,972.72 |
Notes Receivable |
454,630,640.03 |
Accounts Receivable |
1,082,337,157.36 |
Advances to Suppliers |
106,638,703.47 |
Other Receivables |
18,243,897.43 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,304,907,137.19 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
3,643,711.04 |
Other Current Assets |
162,969,874.26 |
Total Current Assets |
5,056,321,436.16 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
142,648,893.72 |
Investment Properties |
276,156.91 |
Fixed Assetes |
1,637,373,197.71 |
Under-construction Projects |
522,871,705.40 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
359,730,960.71 |
R&D expenses |
-- |
Goodwill |
50,949,485.46 |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
71,893,209.61 |
Other Non-Current Assets |
1,458,180,505.52 |
Sub-Total of Non-Current Assets |
4,505,896,325.28 |
Total Assets |
9,562,217,761.44 |
Short-Term Loans |
1,425,692,797.22 |
Trading Financial liabilities |
-- |
Notes Payable |
1,499,759,649.13 |
Accounts Payable |
242,915,123.97 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
28,820,500.69 |
Taxes Payable |
6,610,766.43 |
Interest Payable |
123,512,484.58 |
Dividend Payable |
-- |
Other payables |
179,183,170.48 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
35,702,742.95 |
Other Current Liabilities |
1,197,101.44 |
Sub-Total of Current Liabilities |
3,429,758,659.53 |
Long-term Loans |
344,423,833.33 |
Bonds Payable |
1,044,458,717.27 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
11,320,091.98 |
Deferred Income Tax Liabilities |
30,028,783.51 |
Other Non-Current Liabilities |
670,000,000.00 |
Sub-Total of Non-Current Liabilities |
2,130,461,046.97 |
Total Liabilities |
5,560,219,706.50 |
Paid-In Capital(Or Share Stock) |
329,708,796.00 |
Capital Surplus |
1,857,240,087.39 |
Surplus Reserve |
127,143,486.92 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,415,037,013.05 |
Minority Stockholder's Interest |
89,033,838.31 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,912,964,216.63 |
Owner's Equity(Stockholder's Equity) |
4,001,998,054.94 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
9,562,217,761.44 |